Jeremy Samuel Faust, MD, MS, MA
Jeremy Samuel Faust, MD, MS, MA
Editor-in-Chief

Brief19.com editor-in-chief, Dr. Jeremy Samuel Faust MD MS, is a proud emergency physician at Brigham and Women’s Hospital in the division of health policy and public health, and an instructor at Harvard Medical School. His writing has appeared in the New York Times, the Washington Post, The Boston Globe, The Atlantic, Scientific American, and appears frequently in Slate. He has appeared on CNN, CNBC, MSNBC, NBC, FOX, ABC’s 20/20, NPR and others. Academic writing credits include the Journal of the American Medical Association, the BMJ, Lancet Oncology, and the Annals of Emergency Medicine, where he serves as an associate editor for News and Perspectives. He is medical editor-in-chief of ACEP Now, the monthly magazine of the American College of Emergency Physicians. He is also the co-host of the award-winning medical education FOAMcast. His primary hobby is serving as the artistic director and conductor of the Longwood Chorus, an 80-voice ensemble of health care professionals and students dedicated to creating high quality choral music in Boston. He is board president and artistic advisor of the GRAMMY-award winning ensemble Roomful of Teeth. His favorite movie, by a substantial margin, is Casablanca.

Articles

Both Pfizer/BioNtech and Moderna vaccines remain active against India variants
CDC changes mask guidelines for the vaccinated. What can you do? Everything
A possible treatment for rare vaccine-induced blood clotting emerges
Independent Panel for Pandemic Preparedness and Response issue covid-19 redux
Vaccine acceptance and disparities among incarcerated people
Pfizer/BioNtech vaccine data indicates 100 percent reduction in SARS-CoV-2 among US children ages 12-15. Will it save any lives? Almost certainly
Pfizer/BioNtech data from Israel. Four key takeaways including why the second dose matters
New goal set for US vaccinations: 70 percent by the Fourth of July
US Food and Drug Administration set to expand Pfizer/BioNtech vaccine to adolescents ages 12-15
mRNA vaccines appear to have no effect on rates of facial paralysis or weakness
Middle seats: bad. Airport-based testing: good
Organ transplants and reinfection. Viral genetics answer a crucial question
FDA revokes emergency use authorization for monoclonal antibody bamlanivimab
The Covid-19 pandemic and suicide. Data from 21 high- and upper-middle-income nations suggests lower or unchanged rates
Johnson & Johnson vaccine pause still in effect
Johnson & Johnson vaccine rollout paused in the United States. Why baseline rates are everything
AstraZeneca/Oxford vaccine link to dangerous blood clotting disorder looks real and rare. Should it be avoided? Maybe in young adults in some circumstances
CDC updates guidance on cleaning surfaces to prevent SARS-CoV-2 infection. Will "hygiene theater" stop?
Can vaccinated people who get coronavirus spread it? We will know sometime this year.
Pediatric coronavirus vaccines trials won't report on efficacy. Why that's not a problem and how to sign children up
Shelter-in-place and weight changes. Did people gain or lose a few?
Vaccine hesitancy among healthcare workers lowered over time, followed emerging evidence, FDA policy, and media coverage of rollouts
Coronavirus antibody levels of children and adults differ widely in response to infection, new study finds
*Brief19* turns one. What we've learned and how our guiding principles have worked. (And yes, a little new research on Vitamin D as well)
Moderna vaccine shows reduced activity against South Africa B.1.351, Brazil (P.1), and California (B.1.427/B.1.429) coronavirus variants. However, it remains highly active against U.K. B.1.1.7 variant
Moderna Vaccine Shows Reduced Activity Against South Africa B.1.351, Brazil (P.1), and California (B.1.427/B.1.429) Coronavirus Variants. However, it Remains Highly Active Against U.K. B.1.1.7 Variant (breaking)
Mass vaccination sites are working. But they require mass coordination
CDC and Medicare and Medicaid Federal agencies relax nursing home visit guidelines
Kids and seroprevalence: good news or a double-edged sword?
Major NIH-Funded Trial of Convalescent Plasma in Covid-19 Outpatients Stopped Early Due to Futility (breaking)
Antibodies to SARS-CoV-2 are highly protective against future infection, but not perfect
CDC says vaccinations mean quarantine not necessary for all, with caveats galore and incomplete evidence to back it up
CDC says vaccinations mean quarantine not necessary for all, with caveats galore and incomplete evidence to back it up
A new report suggests why convalescent plasma may harm some people, and possibly lead to new variants
More evidence that coronavirus vaccines in use may decrease transmission. The question is when?
Mask mandates associated with fewer hospitalizations in the weeks after implementation
Is one dose of the vaccine enough for people with evidence of prior coronavirus infection? New impressive data sheds light
New data gives insight on how long patients can spread coronavirus
Covid-19 risks to pregnant patients. New data shows risk of serious complications are increased but remain rare
An in-depth analysis of Biden’s proposed stimulus package (breaking)
Preterm births were said to have decreased during "lockdowns." Better data now suggests that didn't happen
Vaccinations expand. New York opens the gates to the next wave
Covid-19 symptoms at 6 months. New research on what we've learned about the long-haul
Stay-at-home orders saved lives and changed many others
The new coronavirus strain and vaccine effectiveness
Shorter quarantines can eliminate most contagion. Is most enough? New data
New vaccine guidance for people with weakened immune systems and those with a history of Guillan-Barré Syndrome or Bell's Palsy
Stimulus bill signed into law. Pandemic emergency unemployment compensation had expired over the weekend
New round of provider relief fund payments
Approaching consensus on a stimulus package
Safety of consumer-grade face masks
Growing divide in vaccine allocation
Covid-19 deaths among young adults in some areas temporarily rivaled or exceeded opioid deaths in parts of the US this year
Vaccinations begin. Who will and won't roll up their sleeve and what can be done to increase the numbers? Black women are leading the way
Azithromycin fails to deliver on covid-19 outcomes
Some covid-19 patients require a second hospitalization. How do they fare?
Fears of influenza and covid-19 coinfection appear to be fading
Emergency physician dismissed for sounding the alarm on hospital capacity
One giant leap for humankind. The promise of vaccines becomes a reality, the United Kingdom begins to vaccinate its population
Dr. Rochelle Walensky named Centers for Disease Control and Prevention Director
An autopsy of Scott Atlas' tenure at the White House: A portrait of disgrace
We are thinking about test performance all wrong. Here's a better way
Brief19's Outbreak Data Tracker
"Any Given Thursday." How many Americans became asymptomatic transmitters today?
Oxford/AstraZeneca vaccine 62% or 90% effective against covid-19, depending on dose
Can you test your way out of a second lockdown? Yes
A note on Moderna
Fluvoxamine shows promise in treating covid-19. Should it? Who cares?
Pfizer releases exciting vaccine effectiveness datum. (Datum is the singular of data)
President-elect Joseph R. Biden assembling new coronavirus taskforce
Drops in coronavirus fatality rates mostly hinge on age, study confirms
Can the prick of a finger produce enough blood for a reliable coronavirus antibody test?
Update on Regeneron
A decrease in medical care during the pandemic. Why that may not mean what you think
Suicides and the covid-19 pandemic. Good news from three countries
Focus on monoclonal antibodies
Why is the Trump administration so "e-mask-ulated"?
The CDC releases "interim considerations" for school-based coronavirus testing
FLOTUS makes a covid-19 statement, falsely implying vitamins have a role in treatment
Monoclonal Antibody Trial Halted for Safety Concern (breaking)
Vaccine update: White House turns on its own Food and Drug Administration
What is the prognosis for the President of the United States?
President Trump and First Lady of the United States have SARS-CoV-2 (breaking)
Improved methods for seroprevalence surveillance provide new and better answers
Confusion on aerosol transmission at the CDC
The CDC orders a halt on evictions after Congress fails to extend the CARES Act
AstraZeneca halts vaccine trial due to a possible serious side effect in one patient
Top physicians turning against FDA commissioner
CDC walks back guidance against testing asymptomatic people
FDA commissioner walks back misleading statements on plasma
A Note From Brief19
Americans get more than ballots by mail. They also get their medications
Covid-19 versus 1918 H1N1 "Spanish flu." They belong in the same conversation
Two major organizations release an election safety guideline. Yes, it can be done.
Is flying during the pandemic safe? A new estimate paints a rosy picture.
Do symptomatic and asymptomatic patients stay positive for SARS-CoV-2 for the same period of time? A new study sheds light and offers other insights.
Do young children with covid-19 have more viral genetic material in their upper airways than adults? A new study says yes. We are not so sure
The FDA seeks home-based coronavirus tests. Will they work?
Knowledge gaps on covid-19 are also pandemic. The Aussies weigh in
Reality star turned President uses hydroxychloroquine falsehoods to distract
The AMA comes out against permanent relaxing of "scope of practice rules"
Another major trial finds hydroxychloroquine offers no covid-19-relatd benefit
Can I see my ENT during covid-19? Yes. But will they see you? Probably
Two SARS-CoV-2 vaccine trials report progress in world’s first Phase II data
How long do symptoms last after recovering from covid-19 infection? 
Contact tracing in Italy identifies high rate of asymptomatic SARS-CoV-2
Dexamethasone appears to be first drug shown to reduce covid-19 deaths
FDA provides updates on antibody test accuracy
At home deaths increased in New York in March and April
Coronavirus knowledge and behavior survey reveals gaps and disparities
Steroids to the rescue? A major finding announced via press release
Symptom-free patients from the Diamond Princess Cruise studied
Scientists tweet against a new paper that caught fire on social media
Self-administered SARS-CoV-2 testing put to the test
Here comes the sun. Will weather help covid-19?
WHO me? Comments on symptom-free disease walked back
The WHO causes confusion on contagion
Two studies of pediatric outcomes in hospitalized patients
Surgisphere scandal fallout continues
Two major studies under cloud of suspicion
Hydroxychloroquine ineffective in preventing SARS-CoV-2
April study on the ineffectiveness of some masks retracted by major journal
Editorial Board Memorandum
Lancet study on hydroxychloroquine under scrutiny
Working safely in an unsafe era
Remdesivir update: a trial without a placebo somehow fails
Black patients hospitalized at disproportionately higher rates. What does this mean?
Not all PPE recycling works
Neurologic disease in covid-19 patients with acute respiratory distress syndrome
Alabama opened on April 30th. Now intense care units are full
Second infections may not be contagious
President Trump says he takes hydroxychloroquine
Message in a bottle. Moderna’s mRNA vaccine candidate makes a splash
Briefing from the editor: This is not the flu
Getting back in the game
Does tuberculosis vaccination protect against SARS-CoV-2?
Lions and tigers and cats? Oh no!
Failure to launch: New York data on hydroxychloroquine use shows no benefit
Consciously unmasking
Covid-19 and blood clots? Dermatologists weigh in
Lancet Lifts Embargo to Sound Cautionary Note about Remdesivir (breaking)
The Lancet has unexpectedly lifted an embargo on a remdesivir trial (breaking)
The Centers for Disease Control and Prevention COVID-19 Nationwide Tracking System is Now Live (exclusive)